Choreo LLC Lowers Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Choreo LLC decreased its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 25.5% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 2,653 shares of the medical instruments supplier’s stock after selling 906 shares during the period. Choreo LLC’s holdings in ICU Medical were worth $409,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of ICUI. FMR LLC raised its holdings in ICU Medical by 2,676.6% in the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier’s stock valued at $18,968,000 after acquiring an additional 100,345 shares during the last quarter. State Street Corp grew its position in shares of ICU Medical by 9.3% in the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock valued at $165,384,000 after purchasing an additional 77,506 shares during the period. Geode Capital Management LLC increased its stake in ICU Medical by 9.6% in the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after purchasing an additional 48,106 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in ICU Medical by 10.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock worth $54,868,000 after buying an additional 27,927 shares during the period. Finally, Principal Financial Group Inc. boosted its stake in ICU Medical by 24.6% in the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock worth $23,130,000 after buying an additional 25,031 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

Insiders Place Their Bets

In other ICU Medical news, COO Christian B. Voigtlander sold 1,962 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $169.08, for a total value of $331,734.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $162.91, for a total transaction of $1,954,920.00. Following the sale, the chief executive officer now owns 104,593 shares in the company, valued at $17,039,245.63. This represents a 10.29 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 17,737 shares of company stock worth $2,879,752 over the last ninety days. 6.70% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ICUI. Jefferies Financial Group raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective for the company in a research note on Wednesday, December 11th. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Finally, KeyCorp boosted their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $199.67.

ICU Medical Stock Down 0.6 %

Shares of NASDAQ:ICUI opened at $156.94 on Thursday. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26. The stock has a 50-day simple moving average of $160.73 and a 200-day simple moving average of $164.16. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The stock has a market capitalization of $3.84 billion, a P/E ratio of -34.34 and a beta of 0.63.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.